about
The Role of Copper Chaperone Atox1 in Coupling Redox Homeostasis to Intracellular Copper DistributionCopper phenotype in Alzheimer's disease: dissecting the pathwayThe DTI connectivity of the human claustrumIntracranial Lesions with Low Signal Intensity on T2-weighted MR Images - Review of Pathologies.Frequency-dependent changes in the amplitude of low-frequency fluctuations in patients with Wilson's disease: a resting-state fMRI studyInherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment.Diverse functional properties of Wilson disease ATP7B variants.Endogenous formation and repair of oxidatively induced G[8-5 m]T intrastrand cross-link lesion.Quantification of oxidative DNA lesions in tissues of Long-Evans Cinnamon rats by capillary high-performance liquid chromatography-tandem mass spectrometry coupled with stable isotope-dilution method.Social cognition in Wilson's disease: A new phenotype?Advance in the pathogenesis and treatment of Wilson disease.Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease.Central pontine myelinolysis associated with Wilson disease in a 7-year-old childCardiac involvement in hereditary ataxiasEstablishment of hepatic and neural differentiation platforms of Wilson's disease specific induced pluripotent stem cellsMicrobial peptide de-coppers mitochondria: implications for Wilson disease.Vessel-specific quantification of blood oxygenation with T2-relaxation-under-phase-contrast MRI.Intracranial lesions with high signal intensity on T1-weighted MR images - review of pathologies.Treatment of Wilson's disease motor complications with deep brain stimulation.Structural and metabolic changes in Atp7b-/- mouse liver and potential for new interventions in Wilson's disease.Parkinson's disease: chameleons and mimics.Nanomaterials and neurodegeneration.The early molecular processes underlying the neurological manifestations of an animal model of Wilson's disease.Identification of two novel mutations in the ATP7B gene that cause Wilson's disease.Age-dependent changes of cerebral copper metabolism in Atp7b -/- knockout mouse model of Wilson's disease by [64Cu]CuCl2-PET/CT.The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician.Effects of copper toxicity on response inhibition processes: a study in Wilson's disease.Renal impairment in different phenotypes of Wilson disease.Hepatocellular carcinoma in a young man with resting and postural tremors.Potent and long-lasting inhibition of human P2X2 receptors by copper.Dystonic Dysarthria in Wilson Disease: Efficacy of Zolpidem.Neurotoxicity of Metal Mixtures.Alteration of Copper Fluxes in Brain Aging: A Longitudinal Study in Rodent Using 64CuCl2-PET/CT.Neurotoxicity of Copper.Elevated serum brain natriuretic peptide and matrix metalloproteinases 2 and 9 in Wilson's disease.Intracerebroventricular administration of the (1→6)-β-d-glucan (lasiodiplodan) in male rats prevents d-penicillamine-induced behavioral alterations and lipoperoxidation in the cortex.The Wilson films--Wilson's disease.Production of Wilson Disease Model Rabbits with Homology-Directed Precision Point Mutations in the ATP7B Gene Using the CRISPR/Cas9 System.[Genetics of tremor].Coexisting Parkinson's and Wilson's Disease: Chance or Connection?
P2860
Q26740516-748BB63D-B13F-4C99-9E12-5198B8D21FE5Q28294380-9563D2BD-450F-43CF-971B-9113DE7E2247Q28650084-17C4AFEA-4C3D-4BA4-8F7E-80B12DAC3E5EQ30886455-A0AA2825-817C-4564-9189-3F2439F3FABBQ33639391-6F6C0347-93DD-42C2-8B83-761A4FEE53E0Q34028117-DA7DD48C-E38B-4B18-B090-D21C06473691Q34125926-F67BC69C-1908-47E5-8DDA-1C4829839DA1Q34267490-7E6C71C8-4CBA-4309-AC14-FC2EC071B2EBQ34669399-326258D5-EEA0-4839-8CCE-59AA333E883DQ36337867-A9B5FA6E-71AE-4264-A296-EDB3A3D29275Q36478429-7134A8E5-91A8-4C53-BBBA-945916126421Q36638550-5B22357F-46B5-41E4-8108-B191D255FCF6Q36894792-0DB83E4A-6A55-4188-B8ED-AA7AB274873DQ36908105-17081666-4895-48EF-915A-D268495AE312Q36923022-CA67EC55-8DBC-404A-8235-3FF636D3489AQ37042204-43665DCD-68B6-4468-845E-40D5D8694A1BQ37678683-7355F758-DB22-4425-BD0E-F3BB64D9D3FEQ38186020-B7099B56-3177-44A6-BD93-1561667A75F5Q38189115-AFD52141-5E13-44DD-8F4C-005BF08ED432Q38201793-A5FE2A0E-BAFC-4C4D-9CAF-FFE1B490953AQ38254117-46A809F1-73E8-47B1-9C48-398F71FA3BF6Q38334868-09A05906-8F75-4367-AD5D-DA8540DD9C17Q38491412-AB16DC50-8A05-41C8-9CAF-D6D2EDCFEF7EQ38600958-169B6F1D-6136-4514-B3F3-2548D105922DQ38994399-2CF7616F-48EA-4A65-B7C7-C746EA238DA9Q40464231-F5C15CC6-0FBE-4116-822A-0C7FFFB6A4CDQ40464829-241A285D-70D1-489C-94DA-BAFF78BE2486Q40685450-BF3B495C-63B0-4C12-A113-4E734A252518Q42009817-17D14E22-BFC9-41D1-B489-B3265B08E1E2Q42768651-BD78B7B8-ACB1-4E33-9296-48EC81CFFFCFQ45986951-DDAEFB39-63EA-4964-A319-4B60BA801D01Q46309582-C0215204-968E-4DDC-BA6A-4D2234958053Q47824838-2FE4A34C-AD9C-43B2-8503-646953596565Q48120135-79A154C2-C706-4D71-9C7A-26EACC24E4FDQ48127447-90FACB42-1CC1-46C9-A1E8-566AD834B6BEQ48273092-54B7B5CD-1E44-48AA-94B1-2A4137A1AFF8Q48518846-0E801193-1F69-46AE-BF73-8BAA8F806ACEQ49417992-817C720B-1724-47AD-9898-DA1CE3702CCBQ50073947-1DFE77CE-EA79-4EF9-B0CE-04FB7D1C4BF0Q50224412-1805F69A-34B6-4155-A13E-4C690812ABDD
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Neurologic Wilson's disease.
@ast
Neurologic Wilson's disease.
@en
Neurologic Wilson's disease.
@nl
type
label
Neurologic Wilson's disease.
@ast
Neurologic Wilson's disease.
@en
Neurologic Wilson's disease.
@nl
prefLabel
Neurologic Wilson's disease.
@ast
Neurologic Wilson's disease.
@en
Neurologic Wilson's disease.
@nl
P2860
P1476
Neurologic Wilson's disease.
@en
P2093
Matthew T Lorincz
P2860
P304
P356
10.1111/J.1749-6632.2009.05109.X
P407
P577
2010-01-01T00:00:00Z